Neuroprotective effects of natural compounds on neurotoxin-induced oxidative stress and cell apoptosis

References

• Aseervatham GSB, Sivasudha T, Jeyadevi R, Ananth DA. Environmental factors and unhealthy lifestyle influence oxidative stress in humans-an overview. Environ Sci Pollut Res Int. 2013;20(7):4356–69.
   PubMed Web of Science ®Google Scholar
• Popa-Wagner A, Mitran S, Sivanesan S, Chang E, Buga AM. ROS and brain diseases: the good, the bad, and the ugly. Oxid Med Cell Longev. 2013;2013, 963520.
   PubMed Web of Science ®Google Scholar
• Metodiewa D, Koska C. Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview. Neurotox Res. 2000;1(3):197–233.
   PubMed Web of Science ®Google Scholar
• Steinbrenner H, Sies H. Selenium homeostasis and antioxidant selenoproteins in brain: implications for disorders in the central nervous system. Arch Biochem Biophys. 2013;536(2):152–7.
   PubMed Web of Science ®Google Scholar
• Barnham KJ, Masters CL, Bush AI. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov. 2004;3(3):205–14.
   PubMed Web of Science ®Google Scholar
• Kadiiska MB, Basu S, Brot N, Cooper C, Csallany AS, Davies MJ, et al. Biomarkers of oxidative stress study V: ozone exposure of rats and its effect on lipids, proteins, and DNA in plasma and urine. Free Radic Biol Med. 2013;61:408–15.
   PubMed Web of Science ®Google Scholar
• Avery SV. Molecular targets of oxidative stress. Biochem J. 2011;434:201–10.
   PubMed Web of Science ®Google Scholar
• Ndhlala AR, Moyo M, Staden JV. Natural antioxidants: fascinating or mythical biomolecules? Molecules. 2010;15(10):6905–30.
   PubMed Web of Science ®Google Scholar
• Koppula S, Kumar H, More SV, Kim BW, Kim IS, Choi DK. Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease. Int J Mol Sci. 2012;13(8):10608–29.
   PubMed Web of Science ®Google Scholar
• Ju HY, Chen SC, Wu KJ, Kuo HC, Hseu YC, Ching H, et al. Antioxidant phenolic profile from ethyl acetate fraction of Fructus Ligustri Lucidi with protection against hydrogen peroxide-induced oxidative damage in SH-SY5Y cells. Food Chem Toxicol. 2012;50(3-4):492–502.
   PubMed Web of Science ®Google Scholar
• Finkelstein E, Rosen GM, Rauckman EJ. Spin trapping of superoxide and hydroxyl radical: practical aspects. Arch Biochem Biophys. 1980;200(1):1–16.
   PubMed Web of Science ®Google Scholar
• Falkowski PG, Godfrey LV. Electrons, life and the evolution of earth's oxygen cycle. Philos Trans R Soc Lond B-Biol Sci. 2008;363(1504):2705–16.
   PubMed Web of Science ®Google Scholar
• Venditti P, Stefano LD, Meo SD. Mitochondrial metabolism of reactive oxygen species. Mitochondrion. 2013;13(2):71–82.
   PubMed Web of Science ®Google Scholar
• Förstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):829–37.
   PubMed Web of Science ®Google Scholar
• Whangbo MH, Williams JM, Leung PCW, Beno MA, Emge TJ, Wang HH. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution. Inorg Chem. 1985;24(22):3502–4.
   Web of Science ®Google Scholar
• Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245–313.
   PubMed Web of Science ®Google Scholar
• Fritz KS, Petersen DR. An overview of the chemistry and biology of reactive aldehydes. Free Radic Biol Med. 2013;59:85–91.
   PubMed Web of Science ®Google Scholar
• Williams DH, Stone MJ, Hauck PR, Rahman SK. Why are secondary metabolites (natural products) biosynthesized? J Nat Prod. 1989;52(6):1189–208.
   PubMed Web of Science ®Google Scholar
• Clardy J, Walsh C. Lessons from natural molecules. Nature. 2004;432(7019):829–37.
   PubMed Web of Science ®Google Scholar
• Koehn FE, Carter GT. The evolving role of natural products in drug discovery. Nat Rev Drug Discov. 2005;4(3):206–20.
   PubMed Web of Science ®Google Scholar
• Newman DJ, Cragg GM. Natural products as sources of new drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–61.
   PubMed Web of Science ®Google Scholar
• Kennedy DO, Wightman EL. Herbal extracts and phytochemicals: plant secondary metabolites and the enhancement of human brain function. Adv Nutr. 2011;2(1):32–50.
   PubMed Web of Science ®Google Scholar
• Kritis AA, Stamoula EG, Paniskaki KA, Vavilis TD. Researching glutamate-induced cytotoxicity in different cell lines: a comparative/collective analysis/study. Front Cell Neurosci. 2015;9:91.
   PubMed Web of Science ®Google Scholar
• Ohnuma K, Hayashi Y, Furue M, Kaneko K, Asashima M. Serum-free culture conditions for serial subculture of undifferentiated PC12 cells. J Neurosci Methods. 2006;151(2):250–61.
   PubMed Web of Science ®Google Scholar
• Biedler JL, Tarlov SR, Schachner M, Freedman LS. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 1978;38(11 Part 1):3751–7.
   PubMed Web of Science ®Google Scholar
• Krishna A, Biryukov M, Trefois C, Antony PMA, Hussong R, Lin J, et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for Parkinson's disease. BMC Genomics. 2014;15(1):1154.
   PubMedGoogle Scholar
• Maher P, Schubert D. Signaling by reactive oxygen species in the nervous system. Cell Mol Life Sci. 2000;57(8-9):1287–305.
   PubMed Web of Science ®Google Scholar
• Maher P, Davis JB. The role of monoamine metabolism in oxidative glutamate toxicity. J Neurosci. 1996;16(20):6394–401.
   PubMed Web of Science ®Google Scholar
• G.Rössler O, Bauer I, Chung HY, Thiel G. Glutamate-induced cell death of immortalized murine hippocampal neurons: neuroprotective activity of heme oxygenase-1, heat shock protein 70, and sodium selenite. Neurosci Lett. 2004;362(3):253–7.
   PubMed Web of Science ®Google Scholar
• Pallast S, Arai K, Wang X, Lo EH, van-Leyen K. 12/15-Lipoxygenase targets neuronal mitochondria under oxidative stress. J Neurochem. 2009;111(3):882–9.
   PubMed Web of Science ®Google Scholar
• Borner C. The Bcl-2 protein family: sensors and check-points for life-or-death decisions. Mol Immunol. 2003;39(11):615–47.
   PubMed Web of Science ®Google Scholar
• Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 1998;281(5381):1312–6.
   PubMed Web of Science ®Google Scholar
• Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997;22(8):299–306.
   PubMed Web of Science ®Google Scholar
• Zhang DD. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev. 2006;38(4):769–89.
   PubMed Web of Science ®Google Scholar
• Kaspar JW, Niture SK, Jaiswal AK. Nrf2: inrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med. 2009;47(9):1304–9.
   PubMed Web of Science ®Google Scholar
• Kwak MK, Wakabayashi N, Kensler TW. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat Res-Fund Mol M. 2004;555(1-2):133–48.
   PubMed Web of Science ®Google Scholar
• Miura T, Tanno M, Sato T. Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis. Cardiovasc Res. 2010;88(1):7–15.
   PubMed Web of Science ®Google Scholar
• Lau KF, Miller CCJ, Anderton BH, Shaw PC. Expression analysis of glycogen synthase kinase-3 in human tissues. J Pept Res. 1999;54(1):85–91.
   PubMedGoogle Scholar
• Yao HB, Shaw PC, Wong CC, Wan DCC. Expression of glycogen synthase kinase-3 isoforms in mouse tissues and their transcription in the brain. J Chem Neuroanat. 2002;23(4):291–7.
   PubMed Web of Science ®Google Scholar
• Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ. 2006;13(5):730–7.
   PubMed Web of Science ®Google Scholar
• Pan J, Wang G, Yang HQ, Hong Z, Xiao Q, Ren RJ, et al. K252a prevents nigral dopaminergic cell death induced by 6-hydroxydopamine through inhibition of both mixed-lineage kinase 3/c-Jun NH2-terminal kinase 3 (JNK3) and apoptosis-inducing kinase 1/JNK3 signaling pathways. Mol Pharmacol. 2007;72(6):1607–18.
   PubMed Web of Science ®Google Scholar
• Pearson G, Robinson F, Gibson TB, Xu BE, Karandikar M, Berman K, et al. Mitogen-activated protein (MAP) kinase pathway: regulation and physiological functions. Endocr Rev. 2001;22(2):153–83.
   PubMed Web of Science ®Google Scholar
• Ries V, Henchcliffe C, Kareva T, Rzhetskaya M, Bland R, During MJ, et al. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A. 2006;103(49):18757–62.
   PubMed Web of Science ®Google Scholar
• van-der-Heide LP, Ramakers GMJ, Smidt MP. Insulin signaling in the central nervous system: learning to survive. Prog Neurobiol. 2006;79(4):205–21.
   PubMed Web of Science ®Google Scholar
• Rössig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem. 2002;277(12):9684–9.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Meffert MK. Roles for NF-κB in nerve cell survival, plasticity, and disease. Cell Death Differ. 2006;13(5):852–60.
   PubMed Web of Science ®Google Scholar
• Cohen G, Heikkila RE. The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem. 1974;249(8):2447–52.
   PubMed Web of Science ®Google Scholar
• Davison AJ, Legault NA, Steele DW. Effect of 6-hydroxydopamine on polymerization of tubulin. protection by superoxide dismutase, catalase, or anaerobic conditions. Biochem Pharmacol. 1986;35(9):1411–7.
   PubMed Web of Science ®Google Scholar
• Curtius H, Wolfensberger M, Steinmann B, Redweik U, Siegfried J. Mass fragmentography of dopamine and 6-hydroxydopamine. Application to the determination of dopamine in human brain biopsies from the caudate nucleus. J Chromatogr A. 1974;99(0):529–40.
   Google Scholar
• Deumens R, Blokland A, Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol. 2002;175(2):303–17.
   PubMed Web of Science ®Google Scholar
• Curtin JF, Donovan M, Cotter TG. Regulation and measurement of oxidative stress in apoptosis. J Immunol Methods. 2002;265(1-2):49–72.
   PubMed Web of Science ®Google Scholar
• Liu H, Mao P, Wang J, Wang T, Xie CH. Allicin protects PC12 cells against 6-OHDA-induced oxidative stress and mitochondrial dysfunction via regulating mitochondrial dynamics. Cell Physiol Biochem. 2015;36(3):966–79.
   PubMedGoogle Scholar
• Olatunji OJ, Feng Y, Olatunji OO, Tang J, Ouyang Z, Su Z. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties. Biomed Pharmacother. 2016;81:7–14.
   PubMed Web of Science ®Google Scholar
• Magalingam KB, Radhakrishnan A, Haleagrahara N. Rutin, a bioflavonoid antioxidant protects rat pheochromocytoma (PC-12) cells against 6-hydroxydopamine (6-OHDA)-induced neurotoxicity. Int J Mol Med. 2013;32(1):235–40.
   PubMed Web of Science ®Google Scholar
• Han X, Zhu S, Wang B, Chen L, Li R, Yao W, et al. Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity. Neurochem Int. 2014;64:18–23.
   PubMed Web of Science ®Google Scholar
• Magalingam KB, Radhakrishnan A, Haleagrahara N. Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA)-induced toxicity in PC12 cells. BMC Res Notes. 2014;7:49–56.
   PubMedGoogle Scholar
• Ren J, Yuan L, Wang W, Zhang M, Wang Q, Li S, et al. Tricetin protects against 6-OHDA-induced neurotoxicity in Parkinson's disease model by activating Nrf2/HO-1 signaling pathway and preventing mitochondria-dependent apoptosis pathway. Toxicol Appl Pharmacol. 2019;378, 114617.
   PubMed Web of Science ®Google Scholar
• Kim DW, Kt L, Kwon J, Lee HJ, Lee D, Mar W. Neuroprotection against 6-OHDA-induced oxidative stress and apoptosis in SH-SY5Y cells by 5,7-Dihydroxychromone: activation of the Nrf2/ARE pathway. Life Sci. 2015;130:25–30.
   PubMed Web of Science ®Google Scholar
• Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics. 2007;8:166.
   PubMed Web of Science ®Google Scholar
• Doxakis E. Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153. J Biol Chem. 2010;285(17):12726–34.
   PubMed Web of Science ®Google Scholar
• Narasimhan M, Patel D, Vedpathak D, Rathinam M, Henderson G, Mahimainathan L. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronal, SH-SY5Y cells. PLoS One. 2012;7(12). e51111.
   Web of Science ®Google Scholar
• Zhang XS, Ha S, Wang XL, Shi YL, Duan SS, Li ZA. Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway. Neuroscience. 2015;303:489–502.
   PubMed Web of Science ®Google Scholar
• Lou H, Jing X, Wei X, Shi H, Ren D, Zhang X. Naringenin protects against 6-OHDA-induced neurotoxicity via activation of the Nrf2/ARE signaling pathway. Neuropharmacology. 2014;79:380–8.
   PubMed Web of Science ®Google Scholar
• Jing X, Wei X, Ren M, Wang L, Zhang X, Lou H. Neuroprotective effects of tanshinone I against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson's disease through upregulating Nrf2. Neurochem Res. 2016;41(4):779–86.
   PubMed Web of Science ®Google Scholar
• Arumugam TV, Gleichmann M, Tang SC, Mattson MP. Hormesis/preconditioning mechanisms, the nervous system and aging. Ageing Res Rev. 2006;5(2):165–78.
   PubMed Web of Science ®Google Scholar
• Pugazhenthi S, Nesterova A, Sable C, Heidenreich KA, Boxeri LM, Heasley LE, et al. Akt/protein kinase B up-regulates Bcl-2 expression through cAMP response element-binding protein. J Biol Chem. 2000;275(15):10761–6.
   PubMed Web of Science ®Google Scholar
• Luna-López A, Triana-Martínez F, López-Diazguerrero NE, Ventura-Gallegos JL, Gutiérrez-Ruiz MC, Damián-Matsumura P, et al. Bcl-2 sustains hormetic response by inducing Nrf-2 nuclear translocation in L929 mouse fibroblasts. Free Radic Biol Med. 2010;49(7):1192–204.
   PubMed Web of Science ®Google Scholar
• Zhang C, Li C, Chen S, Li Z, Jia X, Wang K, et al. Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways. Redox Biol. 2017;11:1–11.
   PubMed Web of Science ®Google Scholar
• Chong CM, Zhou ZY, Razmovski-Naumovski V, Cui GZ, Zhang LQ, Sa F, et al. Danshensu protects against 6-hydroxydopamine-induced damage of PC12 cells in vitro and dopaminergic neurons in zebrafish. Neurosci Lett. 2013;543:121–5.
   PubMed Web of Science ®Google Scholar
• Watanabe R, Kurose T, Morishige Y, Fujimori K. Protective effects of fisetin against 6-OHDA-induced apoptosis by activation of PI3K-Akt signaling in human neuroblastoma SH-SY5Y cells. Neurochem Res. 2018;43(2):488–99.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huang N, Chen M, Jin H, Nie J, Shi J, et al. Procyanidin protects against 6-hydroxydopamine-induced dopaminergic neuron damage via the regulation of the PI3K/Akt signalling pathway. Biomed Pharmacother. 2019;114, 108789.
   Web of Science ®Google Scholar
• Jha SK, Jha NK, Kar R, Ambasta RK, Kumar P. P38 MAPK and PI3K/AKT signalling cascades in Parkinson's disease. Int J Mol Cell Med. 2015;4(2):67–86.
   PubMed Web of Science ®Google Scholar
• Pedrosa R, Soares-da-Silva P. Oxidative and non-oxidative mechanisms of neuronal cell death and apoptosis by L-3,4-dihydroxyphenylalanine (L-DOPA) and dopamine. Br J Pharmacol. 2009;137(8):1305–13.
   Google Scholar
• Park HJ, Zhao TT, Lee KS, Lee SH, Shin KS, Park KH, et al. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models. Neurochem Int. 2015;83-84:19–27.
   PubMed Web of Science ®Google Scholar
• Zhang LQ, Sa F, Chong CM, Wang Y, Zhou ZY, Chang CC, et al. Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways. J Ethnopharmacol. 2015;170:8–15.
   PubMed Web of Science ®Google Scholar
• Kwon SH, Ma SX, Lee SY, Jang CG. Sulfuretin inhibits 6-hydroxydopamine-induced neuronal cell death via reactive oxygen species-dependent mechanisms in human neuroblastoma SH-SY5Y cells. Neurochem Int. 2014;74:53–64.
   PubMed Web of Science ®Google Scholar
• Kim SM, Park YJ, Shin MS, Kim HR, Kim MJ, Lee SH, et al. Acacetin inhibits neuronal cell death induced by 6-hydroxydopamine in cellular Parkinson's disease model. Bioorg Med Chem Lett. 2017;27(23):5207–12.
   PubMed Web of Science ®Google Scholar
• Kou X, Li J, Bian J, Yang Y, Yang X, Fan J, et al. Ampelopsin attenuates 6-OHDA-induced neurotoxicity by regulating GSK-3β/NRF2/ARE signalling. J Funct Foods. 2015;19:765–74.
   Web of Science ®Google Scholar
• Tian LL, Wang XJ, Sun YN, Li CR, Xing YL, Zhao HB, et al. Salvianolic acid B, an antioxidant from Salvia miltiorrhiza, prevents 6-hydroxydopamine induced apoptosis in SH-SY5Y cells. Int J Biochem Cell Biol. 2008;40(3):409–22.
   PubMed Web of Science ®Google Scholar
• Gibbs PEM, Miralem T, Lerner-Marmarosh N, Tudor C, Maines MD. Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS). J Biol Chem. 2012;287(2):1066–79.
   PubMed Web of Science ®Google Scholar
• Jin H, Kanthasamy A, Ghosh A, Yang Y, Anantharam V, Kanthasamy AG. α-synuclein negatively regulates protein kinase Cδ expression to suppress apoptosis in dopaminergic neurons by reducing p300 histone acetyltransferase activity. J Neurosci. 2011;31(6):2035–51.
   PubMed Web of Science ®Google Scholar
• Dong H, Li R, Yu C, Xu T, Zhang X, Dong M. Paeoniflorin inhibition of 6-hydroxydopamine-induced apoptosis in PC12 cells via suppressing reactive oxygen species-mediated PKCδ/NF-κB pathway. Neuroscience. 2015;285:70–80.
   PubMed Web of Science ®Google Scholar
• Wilhelmus MMM, Nijland PG, Drukarch B, de-Vries HE, van-Horssen J. Involvement and interplay of parkin, PINK1, and DJ1 in neurodegenerative and neuroinflammatory disorders. Free Radic Biol Med. 2012;53(4):983–92.
   PubMed Web of Science ®Google Scholar
• Yang YX, Muqit MMK, Latchman DS. Induction of parkin expression in the presence of oxidative stress. Eur J Neurosci. 2006;24(5):1366–72.
   PubMed Web of Science ®Google Scholar
• Lin CY, Tsai CW. Carnosic acid protects SH-SY5Y cells against 6-hydroxydopamine-induced cell death through upregulation of parkin pathway. Neuropharmacology. 2016;110(Pt A):109–17.
   PubMedGoogle Scholar
• Zhao J, Cheng Y, Yang C, Lau S, Lao L, Shuai B, et al. Botanical drug puerarin attenuates 6-hydroxydopamine (6-OHDA)-induced neurotoxicity via upregulating mitochondrial enzyme arginase-2. Mol Neurobiol. 2016;53(4):2200–11.
   PubMed Web of Science ®Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem. 1992;59(5):1609–23.
   PubMed Web of Science ®Google Scholar
• Jang JH, Surh YJ. Possible role of NF-κB in Bcl-XL protection against hydrogen peroxide-induced PC12 cell death. Redox Rep. 2014;9(6):343–8.
   Google Scholar
• Loh KP, Huang SH, Silva RD, Tan BKH, Zhu YZ. Oxidative stress: apoptosis in neuronal injury. Curr Alzheimer Res. 2006;3(4):327–37.
   PubMedGoogle Scholar
• Avshalumov MV, Rice ME. NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices. J Neurophysiol. 2002;87(6):2896–903.
   PubMed Web of Science ®Google Scholar
• Lei Y, Fu W, Chen J, Xiong C, Wu G, Wei H, et al. Neuroprotective effects of Abacopterin E from Abacopteris penangiana against oxidative stress-induced neurotoxicity. J Ethnopharmacol. 2011;134:275–80.
   PubMed Web of Science ®Google Scholar
• Si CL, Shen T, Jiang YY, Wu L, Yu GJ, Ren XD, et al. Antioxidant properties and neuroprotective effects of isocampneoside II on hydrogen peroxide-induced oxidative injury in PC12 cells. Food Chem Toxicol. 2013;59:145–52.
   PubMed Web of Science ®Google Scholar
• Clementi ME, Pani G, Sampaolese B, Tringali G. Punicalagin reduces H2O2-induced cytotoxicity and apoptosis in PC12 cells by modulating the levels of reactive oxygen species. Nutr Neurosci. 2018;21(6):447–54.
   PubMed Web of Science ®Google Scholar
• Ma S, Liu X, Xun Q, Zhang X. Neuroprotective effect of ginkgolide K against H2O2-induced PC12 cell cytotoxicity by ameliorating mitochondrial dysfunction and oxidative stress. Biol Pharm Bull. 2014;37(2):217–25.
   PubMed Web of Science ®Google Scholar
• Olatunji OJ, Chen H, Zhou Y. Neuroprotective effect of trans-N-caffeoyltyramine from Lycium chinense against H2O2 induced cytotoxicity in PC12 cells by attenuating oxidative stress. Biomed Pharmacother. 2017;93:895–902.
   PubMed Web of Science ®Google Scholar
• Luo T, Zhang H, Zhang WW, Huang JT, Song EL, Chen SG, et al. Neuroprotective effect of Jatrorrhizine on hydrogen peroxide-induced cell injury and its potential mechanisms in PC12 cells. Neurosci Lett. 2011;498(3):227–31.
   PubMed Web of Science ®Google Scholar
• Hu W, Wang G, Li P, Wang Y, Si C, He J, et al. Neuroprotective effects of macranthoin G from Eucommia ulmoides against hydrogen peroxide-induced apoptosis in PC12 cells via inhibiting NF-κB activation. Chem Biol Interact. 2014;224:108–16.
   PubMed Web of Science ®Google Scholar
• Liu Q, Kou JP, Yu BY. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation. Neurochem Int. 2011;58(1):119–25.
   PubMed Web of Science ®Google Scholar
• Kwon SH, Kim JA, Hong SI, Jung YH, Kim HC, Lee SY, et al. Loganin protects against hydrogen peroxide-induced apoptosis by inhibiting phosphorylation of JNK, p38, and ERK 1/2 MAPKs in SH-SY5Y cells. Neurochem Int. 2011;58(4):533–41.
   PubMed Web of Science ®Google Scholar
• Hu XL, Niu YX, Zhang Q, Tian X, Gao LY, Guo LP, et al. Neuroprotective effects of kukoamine B against hydrogenperoxide-induced apoptosis and potential mechanisms in SH-SY5Y cells. Environ Toxicol Pharmacol. 2015;40:230–40.
   PubMed Web of Science ®Google Scholar
• Yan YH, Li SH, Li HY, Lin Y, Yang JX. Osthole protects bone marrow-derived neural stem cells from oxidative damage through PI3K/Akt-1 pathway. Neurochem Res. 2016;42(2):398–405.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Burgos E, Carretero ME, Gomez-Serranillos MP. Involvement of Nrf2 signaling pathway in the neuroprotective activity of natural kaurane diterpenes. Neuroscience. 2013;231:400–12.
   PubMed Web of Science ®Google Scholar
• Greenwood SM, Connolly CN. Dendritic and mitochondrial changes during glutamate toxicity. Neuropharmacology. 2007;53(8):891–8.
   PubMed Web of Science ®Google Scholar
• Baptiste DC, Hartwick ATE, Jollimore CAB, Baldridge WH, Seigel GM, Kelly MEM. An investigation of the neuroprotective effects of tetracycline derivatives in experimental models of retinal cell death. Mol Pharmacol. 2004;66(5):1113–22.
   PubMed Web of Science ®Google Scholar
• Reynolds I, Hastings T. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptor activation. J Neurosci. 1995;15(5):3318–27.
   PubMed Web of Science ®Google Scholar
• Lorenzo HK, Susin SA. Therapeutic potential of AIF mediated caspase-independent programmed cell death. Drug Resist Updat. 2007;10(6):235–55.
   PubMed Web of Science ®Google Scholar
• Tobaben S, Grohm J, Seiler A, Conrad M, Plesnila N, Culmsee C. Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons. Cell Death Differ. 2011;18(2):282–92.
   PubMed Web of Science ®Google Scholar
• Lee SY, Ahn SM, Wang Z, Choi YW, Shin HK, Choi BT. Neuroprotective effects of 2,3,5,4'-tetrahydoxystilbene-2-O-β-D-glucoside from Polygonum multiflorum against glutamate-induced oxidative toxicity in HT22 cells. J Ethnopharmacol. 2017;195:64–70.
   PubMed Web of Science ®Google Scholar
• Ma S, Liu H, Jiao H, Wang L, Chen L, Liang J, et al. Neuroprotective effect of ginkgolide K on glutamate-induced cytotoxicity in PC 12 cells via inhibition of ROS generation and Ca2+ influx. Neurotoxicology. 2012;33(1):59–69.
   PubMed Web of Science ®Google Scholar
• Lv C, Yuan X, Zeng HW, Liu RH, Zhang WD. Protective effect of cinnamaldehyde against glutamate-induced oxidative stress and apoptosis in PC12 cells. Eur J Pharmacol. 2017;815:487–94.
   PubMed Web of Science ®Google Scholar
• Kumari S, Mehta SL, Li PA. Glutamate induces mitochondrial dynamic imbalance and autophagy activation: preventive effects of selenium. PLoS One. 2012;7(6):e39382.
   PubMed Web of Science ®Google Scholar
• Yang EJ, Lee JY, Park SH, Lee T, Song KS. Neuroprotective effects of neolignans isolated from Magnoliae Cortex against glutamate-induced apoptotic stimuli in HT22 cells. Food Chem Toxicol. 2013;56:304–12.
   PubMed Web of Science ®Google Scholar
• Yang EJ, Song KS. Andrographolide, a major component of Andrographis paniculata leaves, has the neuroprotective effects on glutamate-induced HT22 cell death. J Funct Foods. 2014;9:162–72.
   Web of Science ®Google Scholar
• Yang EJ, Park GH, Song KS. Neuroprotective effects of liquiritigenin isolated from licorice roots on glutamate-induced apoptosis in hippocampal neuronal cells. Neurotoxicology. 2013;39:114–23.
   PubMed Web of Science ®Google Scholar
• Timmins JM, Ozcan L, Seimon TA, Li G, Malagelada C, Backs J, et al. Calcium/calmodulin dependent protein kinase II links ER stress with Fas and mitochondrial apoptosis pathways. J Clin Invest. 2009;119(10):2925–41.
   PubMed Web of Science ®Google Scholar
• Yu L, Wang N, Zhang Y, Wang Y, Li J, Wu Q, et al. Neuroprotective effect of muscone on glutamate-induced apoptosis in PC12 cells via antioxidant and Ca2+ antagonism. Neurochem Int. 2014;70:10–21.
   PubMed Web of Science ®Google Scholar
• Stanika RI, Pivovarova NB, Brantner CA, Watts CA, Winters CA, Andrews SB. Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity. Proc Natl Acad Sci U S A. 2009;106(24):9854–9.
   PubMed Web of Science ®Google Scholar
• Sweatt JD. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol. 2004;14(3):311–7.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhao N, Li C, Chang Q, Liu X, Liao Y, et al. Longistyline C acts antidepressant in vivo and neuroprotection in vitro against glutamate-induced cytotoxicity by regulating NMDAR/NR2B-ERK pathway in PC12 cells. PLoS One. 2017;12(9):e0183702.
   PubMed Web of Science ®Google Scholar
• Selkoe DJ. Alzheimer's disease-genotypes, phenotype, and treatments. Science. 1997;275(5300):630–1.
   PubMed Web of Science ®Google Scholar
• Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vitro aging of beta amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991;563(1-2):311–4.
   PubMed Web of Science ®Google Scholar
• Kosik KS, Joachim CL, Selkoe DJ. Microtubule-associated protein tau (tau) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc Natl Acad Sci U S A. 1986;83(11):4044–8.
   PubMed Web of Science ®Google Scholar
• Murvai Ü, Somkuti J, Smeller L, Penke B, Kellermayer MSZ. Structural and nanomechanical comparison of epitaxially and solution-grown amyloid β25-35 fibrils. BBA-Proteins Proteom. 2015;1854(5):327–32.
   PubMed Web of Science ®Google Scholar
• Mao P, Reddy PH. Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics. Biochim Biophys Acta. 2011;1812(11):1359–70.
   PubMed Web of Science ®Google Scholar
• Acquaviva R, Russo A, Galvano F, Galvano G, Barcellona ML, Volti GL, et al. Cyanidin and cyanidin 3-O-beta-D-glucoside as DNA cleavage protectors and antioxidants. Cell Biol Toxicol. 2003;19(4):243–52.
   PubMed Web of Science ®Google Scholar
• Wang Y, Fu XT, Li DW, Wang K, Wang XZ, Li Y, et al. Cyanidin suppresses amyloid beta-induced neurotoxicity by inhibiting reactive oxygen species-mediated DNA damage and apoptosis in PC12 cells. Neural Regen Res. 2016;11(5):795–800.
   PubMed Web of Science ®Google Scholar
• Martin D, Rojo AI, Salinas M, Diaz R, Gallardo G, Alam J, et al. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J Biol Chem. 2004;279(10):8919–29.
   PubMed Web of Science ®Google Scholar
• Kwon SH, Ma SX, Hwang JY, Lee SY, Jang CG. Involvement of the Nrf2/HO-1 signaling pathway in sulfuretin-induced protection against amyloid beta 25–35 neurotoxicity. Neuroscience. 2015;304:14–28.
   PubMed Web of Science ®Google Scholar
• Cui J, Wang J, Zheng M, Gou D, Liu C, Zhou Y. Ginsenoside Rg2 protects PC12 cells against β-amyloid25-35-induced apoptosis via the phosphoinositide 3-kinase/Akt pathway. Chem Biol Interact. 2017;275:152–61.
   PubMed Web of Science ®Google Scholar
• Xiao H, Zhang Q, Peng Y, Tang G, Liao Y, Zhuang X, et al. 7-(4-Hydroxy-3-methoxyphenyl)-1-phenyl-4E-hepten-3-one alleviates Aβ1-42 induced cytotoxicity through PI3K-mTOR pathways. Biochem Biophys Res Commun. 2017;484(2):365–71.
   PubMed Web of Science ®Google Scholar
• Rank KB, Pauley AM, Bhattacharya K, Wang Z, Evans DB, Fleck TJ, et al. Direct interaction of soluble human recombinant Abeta 1-42 results in tau aggregation and hyperphosphorylation by tau protein kinase II. FEBS Lett. 2002;514(2-3):263–8.
   PubMed Web of Science ®Google Scholar
• Leschik J, Welzel A, Weissmann C, Eckert A, Brandt R. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-β in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-β-induced cell death. J Neurochem. 2007;101(5):1303–15.
   PubMed Web of Science ®Google Scholar
• Park SY, Kim HS, Cho EK, Kwon BY, Phark S, Hwang KW, et al. Curcumin protected PC12 cells against beta-amyloid-induced toxicity through the inhibition of oxidative damage and tau hyperphosphorylation. Food Chem Toxicol. 2008;46(8):2881–7.
   PubMed Web of Science ®Google Scholar
• Zeng KW, Ko H, Yang HO, Wang XM. Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells. Neuropharmacology. 2010;59(6):542–50.
   PubMed Web of Science ®Google Scholar
• Rickle A, Bogdanovic N, Volkman I, Winblad B, Ravid R, Cowburn RF. Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport. 2004;15(6):955–9.
   PubMed Web of Science ®Google Scholar
• Liu C, Li Y, Semenov M, Han C, Baeg GH, Tan Y, et al. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell. 2002;108(6):837–47.
   PubMed Web of Science ®Google Scholar
• Lin JW, Chen JT, Hong CY, Lin YL, Wang KT, Yao CJ, et al. Honokiol traverses the blood-brain barrier and induces apoptosis of neuroblastoma cells via an intrinsic bax-mitochondrion-cytochrome c-caspase protease pathway. Neuro Oncology. 2012;14(3):302–14.
   PubMed Web of Science ®Google Scholar
• Xian YF, Ip SP, Mao QQ, Lin ZX. Neuroprotective effects of honokiol against beta-amyloid-induced neurotoxicity via GSK-3β and β-catenin signaling pathway in PC12 cells. Neurochem Int. 2016;97:8–14.
   PubMed Web of Science ®Google Scholar
• Wang DM, Li SQ, Zhu XY, Wang Y, Wu WL, Zhang XJ. Protective effects of hesperidin against amyloid-β (Aβ) induced neurotoxicity through the voltage dependent anion channel 1 (VDAC1)-mediated mitochondrial apoptotic pathway in PC12 cells. Neurochem Res. 2013;38(5):1034–44.
   PubMed Web of Science ®Google Scholar
• Schliebs R, Arendt T. The cholinergic system in aging and neuronal degeneration. Behav Brain Res. 2011;221(2):555–63.
   PubMed Web of Science ®Google Scholar
• Perry EK, Perry RH, Blessed G, Tomlinson BE. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. 1977;1(8004):189.
   PubMed Web of Science ®Google Scholar
• Yan X, Chen T, Zhang L, Du H. Protective effects of Forsythoside A on amyloid beta-induced apoptosis in PC12 cells by downregulating acetylcholinesterase. Eur J Pharmacol. 2017;810:141–8.
   PubMed Web of Science ®Google Scholar
• Meiri KF, Pfenninger KH, Willard MB. Growth-associated protein, GAP-43, a polypeptide that is induced when neurons extend axons, is a component of growth cones and corresponds to pp 46, a major polypeptide of a subcellular fraction enriched in growth cones. Proc Natl Acad Sci U S A. 1986;83(10):3537–41.
   PubMed Web of Science ®Google Scholar
• Brugg B, Matus A. PC 12 cells express juvenile microtubule-associated proteins during nerve growth factor-induced neurite growth. J Cell Biol. 1988;107(2):643–50.
   PubMed Web of Science ®Google Scholar
• Jesky R, Chen H. The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells. BMC Complement Altern Med. 2016;16:26–36.
   PubMed Web of Science ®Google Scholar
• Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. CSH Perspect Biol. 2017;9(7):a028035.
   Google Scholar
• Bhat AH, Dar KB, Anees S, Zargar MA, Masood A, Sofi MA, et al. Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015;74:101–10.
   PubMed Web of Science ®Google Scholar